Prospective registry study investigating medical care in hematooncologic patients with venousthromboembolism in Berli

• Conditions: Phlebitis and thrombophlebitis of superficial vessels of lower extremities; I80.9; C00-C75; I80.0; Phlebitis and thrombophlebitis of unspecified site; Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue

• Registration Number: DRKS00008196
• Lead Sponsor: Vivantes Klinikum im FriedrichshainKlinik für Innere Medizin/Angiologie , Funktionsbereich Hämostaseologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-05-18
• Study Completion: 2017-05-01
• Results First Posted: 2021-12-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 382

Inclusion Criteria

Patients with malignant disease of any kind and newly diagnosed venous thromboembolism who received inpatient or outpatient treatment in the hospitals of Vivantes/Charite. The malignant disease should have been diagnosed or have required treatment during the past two years.Patients with venous thromboembolism in whom malignant disease is diagnosed for the first time, in the course of diagnostic procedures due to venous thrombembolism

Exclusion Criteria

Patients suffering venous thromboembolism but not malignant disease will be registered only once by with reduced baseline documentation. There will be no follow up. They will not take part in follow-up-investigation.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary aim in the context of health care research is the documentation of the actual clinical practice of the treatment of these patients. By means of this registry study it will be possible for the first time to collect data on the patients’ medical history/career and medical pathways.

Secondary Outcome Measures

Name	Time	Method
not relevant